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Introduction
The cyclical nature of geophysical variations in the solar day as well as seasonal changes of the environmental day/night cycle is manifested in all living organisms.
Adaptation to these changes has evolved to include regulation by both an endogenous mechanism known as the "biological clock ", and an exogenous synchronizing component, the environmental Zeitgeber. 1 The circadian periodicity, which is regulated by the suprachiasmatic nucleus (SCN) of the hypothalamus, the body´s main "biological clock", is approximately 24.2h. This periodicity is synchronized to exactly 24.0 h by the external light/dark (LD) cycle acting through retinal-hypothalamic links. 2, 3 Desynchronization of these circadian rhythms occurs under various conditions of environmental insult giving rise to different kinds of circadian rhythm sleep disorders (CRSD). 4 Major CRSD include delayed sleep phase syndrome, advanced sleep-phase syndrome,non-24 h sleep-wake rhythm disorder, free-running sleep disorder, jet lag and shift-work. 5 These circadian rhythm disorders have a major impact on the health, social life and work performance (often negative) of individuals. 6, 7 Jet lag comprises a constellation of symptoms that occurs as a result of disruptions of entrainment associated with time-zone transitions. 7, 8 These symptoms consist of daytime fatigue, impaired alertness, insomnia, loss of appetite, poor psychomotor co-ordination, reduced cognitive skills, and depressed mood. The severity of jet lag symptoms depends on the number of time zones crossed, as well as the direction of travel. Eastbound travel tends to cause difficulties in falling asleep, whereas westbound travel interferes with sleep-maintenance. 9 The disruptive effects of jet lag have been documented at the molecular level of clock genes present in the SCN and peripheral tissues. 1 Eastbound travel causes phase advances in the body's circadian rhythms while westbound flight induces phase delays in circadian rhythms. As a consequence jet travelers are forced to synchronize their bodily rhythms; this resynchronization occurs at a speed of approximately 1.5 h a day after westward flights and approximately 1 h a day after eastward flight irrespective of whether their travel occurs during daytime or night. 7, 10, 11 Regardless of the direction of air travel there is also travel fatigue due to factors such as the cramped seats, altered 4 feeding schedule, poor air quality and inability to sleep. 7, 12, 13 These factors further aggravate the symptoms of jet lag.
Circadian rhythm disturbances in jet lag
Synchronization of circadian rhythms, particularly the sleep/wake rhythm, to environmental LD cycles is essential for maintaining man's normal physical and mental health. 1 showed more rigid responses after the phase-shift. In young (less than 50 yrs) and old pilots (more than 50 yrs), the activity/rest rhythm rapidly adjusted to the new time schedule, whereas the acrophase of the temperature rhythm tended to remain close to the initial schedule. This desynchronization was evident until the return flight (day 5) and persisted at least 1 day after arrival in Madrid. In the case of Madrid-Tokyo flights there was an abrupt phase advance of the activity/rest rhythm coincident with the light/dark Zeitgeber phase shift during the first day, whereas no apparent phase shift in the temperature rhythm was observed. On the second day in Tokyo a phase advance in the temperature rhythm occurred. The return flight to Madrid induced rapid re-entrainment of both rhythms. Among the group of older pilots however the temperature rhythms showed no evidence of entrainment on reaching Tokyo, nor following the return flight to Madrid. 15 Changes in urinary-6 sulphatoxymelatonin and cortisol excretion were consistent with temperature regulation. effect on the quality or the length of sleep was noted. 13, 19, 20 The reduction in daytime activity seen following international air travel is linked to a restriction of the length of nocturnal sleep prior to arrival at the new destination. 21 Several studies have reported on the effects of simulated and real jet lag on sleep-wake problems.
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Management of work schedules for pilots
Improperly designed work schedules which do not take into consideration our present understanding of jet lag effects can significantly impact the health of industry workers such as airline pilots. These health effects include a chronic dysregulation condition with consequent increases in psychophysiological disorders, a higher incidence of stress related emotional changes, and diminished life expectancy. The potential tolerance of employees with regard to age and personality obtained by chronobiological assessment should be taken into account when designing work schedules, including stopover duration and rest periods between flights. [26] [27] [28] [29] [30] The optimal work strategy for this population is a compromise between these extreme alternatives: a long rest period at stopovers until full re-entrainment is achieved, or a short stop accompanied with relative isolation, maintaining the employees' retiring time to which he is accustomed at home so that re-entrainment to the new location is prevented. With an expected re-entrainment schedule equating to 1 h/day westward or 1.5 h/day eastward, the desired layout period can be kept to between 24 h to 2 days to allow enough rest without greatly affecting home circadian rhythmicity.
20,31
Jetlag and athletic performance
It has been shown that elite athletes travelling to the west or east over six to eight time zones demonstrate reduced grip strength and poor performance in training sessions and that these effects last for up to several days after the flight. 32 Decreases in daily profiles of grip strength were also reported for a group of Olympic athletes and sedentary people who travelled eastward over ten time zones. 33 In addition to poor 7 athletic performance, sleep loss and mood disturbances also have also been reported following rapid travel over several time zones.
32,34
Pharmacological management of jet lag: Use of melatonin and its analogs
Several studies have investigated the effectiveness of a number of pharmacological interventions for minimizing jet lag symptoms. Drugs such as modafinil, dextroamphetamine sulphate, and caffeine have been evaluated for their ability to combat tried the fatigue and reduced alertness associated with jet lag. Of these both slow release and fast release caffeine have been found effective. 24, 35, 36 As noted below, several studies have also shown that exogenously administered melatonin can alleviate jet lag symptoms both by causing sleep propensity and by regulating timing of the sleep wake-cycle.
Melatonin is produced in most organisms from algae to primates and participates in various physiological processes. In addition to its effects on sleep and circadian regulatory actions, melatonin has a number of important health maintenance effects, including antioxidant, immunomodulatory, and oncogenic activities. 37 Melatonin has also been found beneficial in modulating pain perception 38 and in protecting against septic shock.
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In mammals including humans, the phase and amplitude of melatonin secretion are considered to act as an "arm" of the biological clock. 40 Due to its predictable regulation by environmental Zeitgebers, melatonin secretion is considered to be a marker or chemical code of the night. Up to a limit, the longer the length of darkness the longer the duration of melatonin secretion. In mammals that are seasonally responsive, the seasonal changes in the hours of light and dark produce parallel patterns of changes in melatonin secretion and those alterations in melatonin cause the seasonal body changes. [41] [42] [43] [44] The timing of melatonin secretion is closely associated with the timing of sleep propensity and coincides with decreases in core body temperature. Melatonin has the capacity to alter the timing of circadian rhythms and functions, thereby synchronizing them with prevailing LD cycles. Melatonin is now used successfully for treating various CRSD and conditions such as shift work disorder. 49 , an effect which has been proposed as the mechanism by which melatonin regulates the sleep-wake cycle. 50 Melatonin's phase shifting effects are mediated through MT 2 melatonin receptors present in SCN. 51 These two melatonin receptors modulate GABA A receptors in the SCN differentially.
52
; these GABA receptors reportedly both phase shift and synchronize SCN clock cells.
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Melatonin in jet lag
In the earlier discussion of jet lag symptoms, it was noted that transmeridian travel affects the sleep, circadian rhythms, and daytime activity of travelers, effects which often take several days to resynchronize to local environmental conditions. The time required for adaptation is generally determined by the size of the phase shift and
Zeitgeber strength. This approximates to an adaptive shift of 1-1.5 h per day, with eastbound flight causing a greater prolongation of symptoms when compared to westbound flights. 54, 55 Melatonin administration has been shown to shift circadian rhythms in humans. [56] [57] [58] This effect is a key factor in melatonin's actions in reducing jet lag symptoms, the therapeutic value of which has now been demonstrated in numerous studies. 24, [59] [60] [61] [62] [63] [64] [65] [66] arrival at the destination point. Significant reductions in jet lag symptoms were reported following melatonin ingestion. 67 Melatonin administration was also found to be of benefit to air-crew members whose jet lag symptoms were significantly reduced following the therapeutic regimen. 60 A meta-analysis of 10 studies using melatonin to alleviate jet lag symptoms found that melatonin taken at bedtime (22:00 h) at the destination of the flight effectively decreased the symptoms of jet lag. 68 The dose of melatonin varied from 0.5 mg to 5.0 mg /day.
A study was conducted on a group of elite sports competitors who travelled from Buenos Aires to Tokyo ( crossing 12 time zones) to participate in the final games of an international soccer competition. 58 The day before leaving Buenos Aires all participants were given 3 mg of melatonin at a time equating to their expected bedtime at Tokyo.
This schedule of melatonin administration was adhered to continuously throughout the entire period of study. Participants were also asked to complete daily sleep log diaries. Upon arrival in Tokyo the subjects performed daily physical exercise out of doors during specific times (08:30 to 11:30 h) in the morning, and from 15:00 to 18:00 h in the afternoon. The purpose of this scheduling was to cover the phase delay and phase advance effects of light symmetrically, as this will influence the phase response curve. 69 . It was hypothesized that this strategically timed restriction of light exposure during the hypothetical minimum of body temperature would produce a contradictory signal for the clock (phase advance with first light exposure and phase delay with second), thus helping to eliminate endogenous phase effects. Exposure to sunlight and physical exercise was avoided at other times of the day. Individual actograms derived from sleep log data revealed that subjects became synchronized within 24 -48 h, well
in advance of what would have been expected in the absence of such a treatment schedule. 58 The findings of the study confirmed the value of a combined intervention approach: the investigators concluded that the timed administration of melatonin, restrictions in light exposure, and physical exercise, when used in a carefully scheduled combined manner, could compensate for the normally expected blunting of endogenous melatonin secretion, and could thus be recommended for overcoming jet lag symptoms in long-haul flights. 10 Similar benefits of combined modality therapy were also found among nonathletes. In a study of the effects of melatonin plus other interventions on jet lag, sedentary volunteers, 75 subjects on an eastbound flight from Sydney to Buenos Aires, and 49 subjects on a westbound flight from Buenos Aires to Sydney both by a transpolar route, were selected for investigation. 70 Passengers on the eastbound flight received 3 mg of melatonin daily 30 minutes before their expected bedtime at Sydney, beginning on the day of the flight and continuing throughout the period of their trip.
All subjects were advised to perform their normal routine and to walk outdoors for at Sydney. Subjects were also advised to maintain sleep diaries throughout the period of study. The sleep log diaries included the evaluation of sleep quality, morning freshness, and daily alertness on a visual analog scale. 70 The mean resynchronization rate was 2.27 ± 1.1 days during the eastbound flight and 2.54 ± 1.3 days for the westbound flight. These findings compared favorably to the expected minimal resynchronization rate after 13 h of flight without any treatment, which is 7 days, thus supporting the conclusion that jet lag symptoms can be significantly reduced by the carefully timed application of melatonin, light exposure and physical activity.
In another study the combined use of slow-release caffeine and melatonin improved several jet lag symptoms during an eastbound flight. 24 For travel of 11-13 h, whether eastbound or westbound, available data from limited field studies indicate that a combination of melatonin, exposure to outdoor light and exercise have a potent ameliorative effect on jet lag symptoms. 42 Analysis of the evidence reviewed above indicates that oral administration of melatonin is the best pharmacological treatment currently available for reducing the symptoms of jet lag. Hence we conclude that strategically timed administration of melatonin is helpful for readjusting the body clock during rapid time-zone transitions and could help millions of air-travellers who suffer from jet lag symptoms.
Potential use of melatonin agonists in jet lag
Ramelteon (Rozerem TM ), a MT 1 /MT 2 melatonin receptor agonist, has been shown in randomized double-blind placebo controlled trials to be effective for treating insomnia. [71] [72] [73] It also has been shown to accelerate re-entrainment of circadian rhythms after an 8 h phase advance of the light -dark cycle in rodents. 74 Compared to melatonin, ramelteon has an affinity for MT 1 and MT 2 melatonin receptors which is 3-16 times greater, and additionally has a longer half life. 75 In addition to its efficacy for treating insomnia, its safety for treating chronic insomnia has been shown in various studies. [76] [77] [78] [79] Ramelteon has been shown to be effective as a phase-shifting agent in humans.
In the first study of its effectiveness for treating CRSD, ramelteon was administered at doses of 1, 2, 4 and 8 mg to 75 affected adult subjects (18-45 yrs) for 6 days. (1-8 mg) was administered 5 min before bedtime (local time) for four nights. Sleep parameters were measured using polysomnography on nights 2, 3, and 4 while nextday residual effects were assessed using psychomotor and memory function tests. 81 Compared to placebo, there was a significant decrease in mean latency to persistent sleep on nights 2-4 with ramelteon 1 mg, but not with 4 or 8 mg doses. The lack of significant reductions at higher doses could be due to the small sample size used for study (n=27 for each ramelteon group) No consistent significant differences were observed with ramelteon vs. placebo on measures of next-day residual effects except on day 4 where participants in all ramelteon groups performed significantly worse. 81 In view of its circadian phase shifting effects, ramelteon could be proposed as a potential therapy for inducing rapid resynchronization following time zone transition of jet travelers. However, further studies on large samples and with more than 8 h phase shifts of jet travel are needed to test the efficacy of ramelteon in different doses in improving sleep quality and day time performance and alertness in healthy adults. 12 Vanda Pharmaceutical has completed phase 2 and 3 studies on the melatonin MT 1 /MT 2 agonist tasimelteon and a randomized controlled trial of for transient insomnia after sleep time shift was recently published. 82 Tasimelteon was effective in reducing sleep onset latency and in resetting the circadian melatonin rhythm, which indicated its potential suitability as treatment for jet lag, shift work and other circadian rhythm sleep disorders. 82 The drug is well tolerated, does not induce impairment of next-day functioning or dependence, and seems to be safe in short-term treatment.
Jet lag, depression and the possible role of agomelatine
As noted above jet lag symptoms are not exclusively physical. Jet airline passengers who have travelled both eastward and westward also frequently report that they have experienced depressive symptoms. [83] [84] [85] Over a six year period Katz and coworkers studied 152 long-distance travelers who had been hospitalized in the Jerusalem Mental Health Center, Kfar Shaul Hospital for psychiatric complaints. 85 The patients were divided into groups based upon the number of time zones crossed. The direction of flight was mainly eastbound. Possible links between jet lag and major depressive disorder or psychotic disorder were evaluated based upon the following criteria: (a) absence of major mental problems before the flight or good remission of existing disorders 1 year or more before the commencement of flight; and, (b) the appearance of major affective syndromes or psychotic syndromes during first 7 days after landing. Although the number of first major affective episodes or psychotic syndromes associated with jet lag were found to be similar among groups the number of relapses occurring conjointly with jet lag was found to be significantly greater in people crossing 7 or more time zones. 85 In earlier studies depression was noted in passengers with westbound flights and mania with eastbound flights. 83, 84 It has been suggested that the transient desynchronization seen in jet travelers can trigger affective disorders. 86 The hypothesis that various subtypes of affective disorders might be the result of rhythm failures (i.e., that they were linked to "free running rhythms") was first
proposed by Halberg et al.. 87 A "free running rhythm" refers to the genetically determined internal rhythm that a healthy individual displays when isolated from all 13 external time cues. When dissociated from these external cues the individually generated rhythm varies somewhat from the normal daily pattern (humans usually showing periods longer than 24 h). A rhythm is said to be "phase advanced" when its peak occurs earlier than its normal pattern and is said to be "phase delayed" when it occurs later.
It has been suggested that internal phase angle disturbances, desynchronizations among various endogenous rhythms, i.e., when these rhythms go in and out of phase with each other, may lie at the heart of depressive disorders. 88, 89 The correction of the phase angle disturbances between sleep-wake cycles and circadian rhythms could thus remove the symptoms of depressive illness triggered by any factor including time-zone transitions.
In addition to the circadian rhythm disturbances, sleep disturbances also constitute the major feature encountered during rapid time-zone transitions. 18, 42 Evidence from epidemiological and electroencephalographic studies additionally implicate sleep disturbances as key factors in the pathogenesis of depressive illness.
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Other evidence consistent with the circadian disruption hypothesis of depression comes from the observation that more than 80 % of depressed patients have complaints of sleep disturbances. [91] [92] [93] and demonstrate a variety of polysomnographic abnormalities. 94 and further that antidepressant therapies that also improve sleep efficiency are especially effective in reducing depressive symptomatology. Moreover, detailed analyses have shown that currently used antidepressants such as selective serotonin reuptake inhibitors exert adverse effects on sleep, and that the antidepressant effect may be counteracted by their effects on sleep. 95, 96 Hence an ideal antidepressant should improve sleep efficiency and reduce depressive symptomatology.
Recently, the melatonergic antidepressant agomelatine has been introduced.
Agomelatine is a novel antidepressant that acts simultaneously as a MT 1 /MT 2 receptor agonist and as a 5HT 2c receptor antagonist. 97, 98 This dual mechanism of action is unique and is the basis for its antidepressant efficacy and for mitigating sleep/wakefulness rhythm disturbances. The effectiveness of agomelatine in improving sleep quality and reducing depressive symptoms has been demonstrated in number of clinical trials. 99-102 14 It has been proposed that the dysregulation of melatonin secretion underlies various circadian-rhythm sleep disorders and depression. 103 A number of clinical studies have reported that melatonin secretion is disturbed in depressives. [104] [105] [106] [107] [108] [109] [110] [111] [112] These results would suggest that melatonin administration might be a useful strategy for mood disorders.
However treatment of depressive disorders with exogenous melatonin alone has not been successful. Nevertheless the introduction of the combined action antidepressant agomelatine, which, as noted above, affects both melatonergic and serotonergic receptors, provides a new therapeutical alternative for the treatment of mood disorders. The chronobiotic action of agomelatine was clinically evaluated in a study conducted in healthy older men. Administration of agomelatine (50 mg) or placebo to 8 healthy older adults for a period of 15 days revealed that agomelatine caused phase advances of an average of 2 h in the temperature profile as well as in the temporal organization of cortisol secretion. 113 These findings suggest that agomelatine is useful as a chronobiotic agent.
Further evidence for agomelatine's usefulness as a treatment for chronobiological disorders emerged from its application in the treatment of seasonal affective disorder (SAD). In chronobiological studies on human subjects, core body temperature and melatonin levels have been used as markers for assessing circadian phase position. Phase delay of the circadian pacemaker relative to the timing of the habitual sleep/wake cycle is considered as one of the major contributing factors in the pathophysiology of SAD. 114 Agomelatine (25mg/day administered in the evening) was used to treat 37 acutely depressed SAD patients for a period of 14 weeks, with treatment outcome being assessed by the SIGH-SAD scale and Circascreen, a self rating scale for the assessment of sleep and circadian rhythm disturbances. 115 Agomelatine treatment caused a significant decrease in SAD symptoms starting from 2 weeks onward.
Conclusion
Jet lag symptoms include daytime fatigue, circadian rhythm sleep disturbances, impaired alertness and many other minor conditions such as gastrointestinal 15 disturbances, hormonal imbalances, and menstrual irregularities. In addition to these well documented effects of jet lag, intercontinental air travel also exacerbates preexisting affective disorders, and can produce severe symptoms in at risk individuals, i.e., those with a history of major depressive disorders.
Although only a few studies have specifically explored the potential linkage between jet lag and major psychiatric disturbance, the frequency of its reported occurrence strongly suggests that this association merits further investigation.
Accumulating evidence shows that jet lag can be managed by a combined treatment program which includes good sleep hygiene, adherence to work-rest schedules in accordance with circadian rhythm principles, the strategically timed use of the well known chronobiotic, melatonin, and limited and carefully timed exposure to environmental light. The melatonergic agonists ramelteon and tasimelteon, which have strong affinity for MT 1 and MT 2 melatonin receptors, and, compared to melatonin, have a longer duration of its action, can be more effective than melatonin alone in reducing the symptoms of jet lag. 
